New York, NY · Founded 2012 · Privately Held (backing)
Developer of a cancer screening blood technology designed to detect cancer markers at early stages. AcuamarkDx is based in New York, NY and was founded in 2012. Its last reported valuation was $85 million in Jun 2024. It has raised $25 million.
Last reported valuation
$85.0M
Oct 2026
Priced at
—
Total raised
$25.0M
Last round
—
Cap table — not yet on record
AcuamarkDx's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AcuamarkDx with a free account
·Watch AcuamarkDx: the Monday email on marks, rounds and moves
